Download PDF
Synfacts 2025; 21(02): 196
DOI: 10.1055/a-2497-0584
Innovative Drug Discovery and Development

Discovery of Clinical Candidate Rezatapopt, a Small-Molecule Reactivator of p53 Y220C Mutants

Contributor(s):
Antonia F. Stepan (Roche)
,
Thomas R. Puleo (Pfizer)
› Further Information
    Permissions and Reprints

Keywords

Rezatapopt - p53 - reactivator


Publication History

Article published online:
28 January 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany